Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice. (scientific article)

Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes.

Q34548512

Recent advances in veterinary vaccine adjuvants

Q35143257

Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-Type Salmonella strains.

Q35475498

STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM

Q36400065

Salmonella enterica serotype Enteritidis and eggs: a national epidemic in the United States

Q36534857

Bioadhesive mannosylated nanoparticles for oral drug delivery

Q40278175

Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development.

Q40477878

Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens

Q40683723

The antibody response to salmonellae in mice and humans studied by immunoblots and ELISA.

Q40774488

Identification of antigens which stimulate T lymphocytes ofSalmonella enteritidis11RX immunized mice

Q41720742

Complementary analysis of the Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and isotope-coded affinity tag technology

Q42610869

Evaluation of the efficacy of oil-emulsion bacterins for reducing fecal shedding of Salmonella enteritidis by laying hens.

Q43328035

Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria

Q43487749

Evaluation of SEF14 fimbrial dot blot and flagellar western blot tests as indicators of Salmonella enteritidis infection in chickens

Q43684568

Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen

Q43740292

Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice.

Q43962321

Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates

Q44185143

Laboratory and field trial assessment of protection given by a Salmonella enteritidis PT4 inactivated, adjuvant vaccine

Q44700705

Salmonella-like bioadhesive nanoparticles

Q46560166

Humoral immune response in hens naturally infected with Salmonella Enteritidis against outer membrane proteins and other surface structural antigens

Q47312399

Protective ability of subcellular extracts from Salmonella Enteritidis and from a rough isogenic mutant against salmonellosis in mice

Q50093720

Vaccination against Salmonella enteritidis in Dutch commercial layer flocks with a vaccine based on a live Salmonella gallinarum 9R strain: evaluation of efficacy, safety, and performance of serologic Salmonella tests.

Q50115579

The relationship between glycogen synthesis, biofilm formation and virulence in salmonella enteritidis.

Q50119296

Correlates of protection induced by live Aro- Salmonella typhimurium vaccines in the murine typhoid model

Q50134874

Airborne challenge of chickens vaccinated orally with the genetically-defined Salmonella enteritidis aroA strain CVL30.

Q50136772

Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi

Q50146372

Development of a novel vaccine delivery system based on Gantrez nanoparticles.

Q51117082

PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems

Q78100595

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

nanoparticle

Q61231

biodegradation

Q696715

Salmonella enteritidis

Q62897324

P304

page(s)

4410-4419

P577

publication date

2007-04-02

P1433

published in

Vaccine

Q7907941

P1476

title

Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice

P478

volume

Reverse relations

cites work (P2860)

Q39151158	Adjuvants for allergy immunotherapeutics.
Q37808118	Designing polymeric particles for antigen delivery
Q59276365	Evaluation of particulate acellular vaccines against Brucella ovis infection in rams
Q84938205	Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice
Q38257645	Nanoparticle based-immunotherapy against allergy.
Q43623067	Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice
Q26825418	Nanoparticulate adjuvants and delivery systems for allergen immunotherapy
Q27011190	Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens
Q42117985	Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation
Q84301195	Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
Q38068954	Recent progress towards development of a Shigella vaccine
Q59798948	Surface engineered polyanhydride-based oral Salmonella subunit nanovaccine for poultry
Q98730992	Temporal dynamics of innate and adaptive immune responses in broiler birds to oral delivered chitosan nanoparticle-based Salmonella subunit antigens
Q36161454	The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice
Q34121001	Using carbon magnetic nanoparticles to target, track, and manipulate dendritic cells

P356	DOI	10.1016/J.VACCINE.2007.03.025
P698	PubMed publication ID	17434651
P5875	ResearchGate publication ID	6393104